David Maldonado, MD
Adult Reconstructive Orthopaedic Surgery · Houston, TXNPI 1083152938
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.0%), speaking fees and grants — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 50.7% of the total. Reporting peaked in 2021 at $41,142 and has fallen 90.6% since, to $3,867 in 2025.
Across 106 payments — averaging $610.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$33K
- Smith+Nephew$17K
- Micromed Inc$10K
- Medinc Of Texas$2K
- Stryker$2K
- Zimmer Biomet$269
- plus $434 from 6 others
What the payments were for
- Speaking & faculty fees$14,07522%
- Grants$10,00015%
- Travel & lodging$5,4268%
- Food & beverage$3,5005%
- Education$31,71749%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 63 | $32,820 |
| Smith+Nephew | 6 | $17,476 |
| Micromed Inc | 8 | $9,600 |
| Medinc Of Texas | 6 | $2,298 |
| Stryker | 13 | $1,821 |
| Zimmer Biomet | 2 | $269 |
| Davol Inc. | 1 | $137 |
| Biocomposites Inc | 1 | $111 |
| Encore Medical, LP | 1 | $74 |
| Medwest Associates | 3 | $50 |
| Medtronic | 1 | $39 |
| Vericel Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,306
- mymobility Platform$146
- REAL INTELLIGENCE$144
- NA$141
- Q-FIX Hip$141
- Q-FIX Shoulder$141
- Latarjet System$141
- Meniscal Root Repair System$141
- NOVOSTITCH PRO$141
- CINCHLOCK$140
- Accelero-None$123
- INSIGNIA$117
- Stimulan$111
How this compares
$64,718 in reported general payments places this provider in the 75th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 89 | $1,794 |
| Pregabalin | 57 | $1,241 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $748 |
| Pantoprazole Sodium | 105 | $712 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 49 | $487 |
| Meloxicam | 180 | $395 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $384 |
| Ondansetron Hcl | 61 | $296 |
| Cyclobenzaprine Hcl | 32 | $168 |
| Mupirocin | 28 | $159 |
| Naproxen | 14 | $133 |
| Tramadol Hcl | 28 | $81 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Houston
- Anay PatelHouston$191K
- Catherine CahillHouston$143K
- Cory CouchHouston$118K
- Robin GoytiaHouston$46K
- Alexander MetoxenHouston$26K
- Nathan RogersHouston$20K
- Clark DormanHouston$15K
- David EdelsteinHouston$13K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.